Email
Password
(Forgot Password?)
Lists member assessment and special studies payments made to CIAR by Philip Morris from 1989-1995. Totals 6-year payments as $24,027,482.00
Offers mailing address for the program manager of a CIAR study at the University of Tulsa. Approves contact of program manager by a vendor but warns: "It would not be advisable for PM to contact him directly without prior clearance from Max Eisenberg at CIAR. (We try to maintain an arm's length relationship with CIAR grantees)."
Forwards e-mail regarding ETS/VTS plan. States preferred format and scope of plan. Indicates need to form "partnerships with academic institutions for research" and to focus efforts on ventilation technology and exposure measurement, not health-related issues. Suggests possible dates for future meeting.
Describes the audience and funding source for the ETSLIT database "managed by the Center for Environmental Health and Human Toxicology (CEHHT) at Georgetown University." States that it is used by "consultants, law firms and other tobacco companies" and that it is funded by the Tobacco Institute and Philip Morris, with funding administration directed by Covington & Burling. Notes that Philip Morris is allowed add entries to the database, upon approval by the database manager.
Discusses work done, and to be completed, on behalf of "five participating [tobacco] companies" in regard to ETS. Notes that an analysis of "IARC and IARC-related publications" has been completed, and a memorandum of IARC quotes is being compiled. States, "we continue to believe that the document will be useful if and when we are called upon to respond to future IARC publications on ETS." Discusses other potential publications and estimated costs for the consultant work, to be divided among the five tobacco companies.
Informs recipient that 189 letters have been mailed out and that "we have exhausted our list of names." Reports that more letters will be mailed when additional names are identified.
Attaches revised IARC Plan [missing] that "addresses the scientific information we will need to pull together, as well as the activities needed to address the media and regulatory impact the study may have around the world." Notes that the plan is the foundation for an "intra-industry" plan to be carried out through IEMC.
Reports on EPA Administrator's statement on the agency's decision on ETS risk assessment and priority initiatives, and revival of an executive order by the Bush administration to standardize federal risk assessment practices. Cites sources.
Cites resolutions passed at CORESTA's Scientific Commission meeting regarding recipients of awards and study grants, naming of the task force on "Disposal of waste tobacco," guidelines for publishing recommended scientific methods, the development of a method "for measuring humectants in tobacco," assignment of responsibilities within the Commission, and the development of publications by Commission sub-groups.
Updates activities of CORESTA Sub-group on Pesticide Residues in relation to the following analytes: organochlorine, maleic hydrazide (MH-30), organophosphorous, ethylene bis-dithiocarbamate (EBDC) and N-methylcarbamate. Anticipates that "the larger part of Sub-group energy in the coming two years will be devoted to MH-30 studies." Notes that questions raised by the ISO TC 126 Secretariat regarding the CORESTA Recommended Method No. 2 ("Determination of Organochlorine Pesticide residues on Tobacco") have been satisfied. Details complications in utilizing current ISO and AOAC methodologies for analyzing MH-30 residues and notes that "ISO are looking to CORESTA for a replacement of the current 4876 standard method." Characterizes problem as "inconsistent results from standard methods being inconsistently followed." Examines option of using Carbon-14 labeled MH-30. Outlines future plans for rectifying difficulties in MH-30 analysis. States that Sub-group members would examine a "new, rapid method" for analysis of organophosphorous pesticide and that "results of analysis for EBDC residues obtained by particular methods differ." Notes that "whether this is a specific laboratory problem or a general method issue has yet to be determined." Briefly describes current method of N-Methylcarbamate analysis.
Lists names of consultants and proposed focus of commentary in relation to ETS health effects, exposure analysis, and risk assessment, and in relation to ventilation, economic and "other" issues. Subdivides ETS health effects into lung cancer, cardiovascular disease, pulmonary and reproductive effects, respectively, and irritation. For each listed consultant, notes if individual "May be appropriate for hearing" and "May be prepared to submit without compensation."
Asks and answers questions about "the Company['s]" policy regarding funding of smoking and health related research. States that "The company provides general grants to universities and provides contributions to a variety of organizations in a manner similar to other corporations. We expect that such grants will be reported and acknowledged by means consistent with the recipient's normal procedures."
Charts plan of action for "Q1-Q4 [quarters?]." Does not explicitly identify issue at hand; ETS is implied. Names individuals from Science, Communications and Government Affairs divisions and identifies steps to be taken by each, per quarter. Divides tasks for each division into broad categories. Science: "scientific community contacts, research and publications, review case control study survey questionnaire, promote sound science, and evaluate Agency priorities." Communications: "develop messages and briefing materials, develop crisis communications plan, media briefings, mobilize NMAs, identify spokespersons," and "IX World Conference on S/H." Government Affairs: "lobbying" and "lock in accommodation where possible."
Addresses three points of contention with IARC study: 1) one of the study centers was removed from the final report due to no reported cases of lung cancer among non-smokers 2)"IARC failed to adhere to its own internal guidelines for conducting epidemiological studies" and 3)the study's relative risk for ETS is too low to provide "useful guidance for health officials or policy makers." For each point, raises questions and/or provides statement to support contention.
Article from junkscience.com website, picked up from Reuters news service. Reports that British tobacco companies issued a legal challenge against a report published by the Scientific Committee on Tobacco and Health (SCOTH) making recommendations to government on the dangers of smoking. Reports on industry's contention that it wasn't consulted and therefore, many of the report's conclusions are 'unsubstantiated and flawed.' States that the tobacco manufacturers' association did provide a "scientific review" on ETS, "the one subject on which it was approached." Reports that the tobacco companies are seeking to have the report withdrawn by SCOTH.
Details communications between representatives of the tobacco industry, including the Tobacco Manufacturers' Association, with representatives of SCOTH in regard to TMA's submission of peer-reviewed scientific papers on ETS and lung cancer, to be considered for inclusion in SCOTH's report on the subject.
Reports on international activities in the areas of ETS/IAQ, OSHA, FDA, Ingredients and Constituents and miscellaneous activities of interest to the tobacco industry. Reports on WRA's response to activities for some of the news bits. Draft copy- includes many handwritten notes and edits.
Reports on international activities in the areas of ETS/IAQ, OSHA, FDA, Ingredients and Constituents and miscellaneous activities of interest to the tobacco industry. Reports on WRA's response to activities for some of the news bits.
Summarizes PM's concern over, and strategies to address, IARC's multi-national study on ETS. Reports that "we are encouraging all PMI markets to step up proactive measures to preempt tough legislation tomorrow w/reasonable restrictions today. And we are also proposing that government adopt criteria for good epidemiology. If adopted by law or regulation these criteria would preclude governments from using the results of studies which don't meet the criteria. And most of the ETS studies to date do not." Requests that strategies be discussed with representatives of Japan Tobacco to "ensure JT regards the IARC threat and this strategy - among others - with the seriousness it deserves."
Forwards commentary on perceived weaknesses of IARC ETS study, and outlines potential "message points" based on those weaknesses. Highlights need for different approach to reviewing the IARC study from scientific and regulatory perspectives. Emphasizes flawed interpretation of observed relative risks for ETS exposure.
Reports that TI response to smoking restrictions has been primarily legal and economic, and that it has failed to successfully address health issues. States that TI has developed scientific witness program to help "counter the anti-smokers' claims about the dangers of ETS." Claims that most effective strategy has been "to broaden the issue to overall indoor air quality and promote improved ventilation as an approach." Cites current media spokespeople promoting this message, and plans to increase activity for 1988. Reports on use of "Truth Squads," ads, workplace smoking literature and materials for the hospitality industry. Estimates costs of Public Smoking Program.
Communicates market activity in eleven Asian markets. Includes data on brands from numerous tobacco manufacturers. Includes an index of brands and manufacturers, respectively. Charts and ranks brands according to varying criteria in different regions (i.e., sales, FTC tar delivery, size). Includes sampling information and methodologies/criteria by which data are reported.
Excerpts conversation between Parrish and "Steve Bayard, principal author of EPA's risk assessment on ETS" at a workplace smoking ban hearing. Notes that conversation was "friendly" and focused on an industry lawsuit in response to the ETS risk assessment. Notes Bayard's commentary: "Why didn't you guys deal with non-cancer effects in the lawsuit? . . . there are real problems with the non-cancer effects. I mean, you guys have taken us to task for violating our cancer guidelines; hell, we don't even have non-cancer guidelines." Implies, through the conversation, that Bayard is a cigar smoker.
Notifies recipient of award in the amount of $186,500.00 to support proposed grant. Stipulates conditions of award: periodic progress reports to Philip Morris, presentation of findings, publication of findings in peer-reviewed journals, and return of funds in excess of research-related expenditures.